Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ · Healthcare
Verrica Pharmaceuticals Inc. Operating Income 2021–2025
Verrica Pharmaceuticals Inc. annual/quarterly operating income history and growth rate from 2021 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Verrica Pharmaceuticals Inc. operating income for the quarter ending March 31, 2026 was -9.7 M, a 19.50% increase year-over-year.
- Verrica Pharmaceuticals Inc. operating income for the twelve months ending March 31, 2026 was -14.7 M, a 81.25% decrease year-over-year.
- Verrica Pharmaceuticals Inc. annual operating income for 2025 was -12.2 M, a 81.52% decrease from 2024.
- Verrica Pharmaceuticals Inc. annual operating income for 2024 was -65.9 M, a 0.24% increase from 2023.
- Verrica Pharmaceuticals Inc. annual operating income for 2023 was -65.8 M, a 208.79% increase from 2022.
- Verrica Pharmaceuticals Inc. annual operating income for 2022 was -21.3 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Verrica Pharmaceuticals Inc. Operating Income — FAQ
Verrica Pharmaceuticals Inc. (VRCA) operating income over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
What is Verrica Pharmaceuticals Inc.'s operating income?
Verrica Pharmaceuticals Inc. (VRCA) reported operating income of -$12M for fiscal 2025.
Where can I see VRCA's operating income history?
The chart and table above show Verrica Pharmaceuticals Inc.'s operating income by year and by quarter, including the growth rate.